Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent ...
To generate successful gene therapies that are capable of delivering nucleic acids to specific cells and tissues, scientists must carefully design their products. They can employ either recombinant ...
Sanofi (SNY) stock is in focus as its AlphaMedix therapy developed with Orano Med succeeds in a mid-stage trial for ...
OmniaBio Inc., a next generation contract development and manufacturing organization (CDMO) pioneering the manufacturing of ...
In recent years, there has been much debate about the role of traditional therapy in psychedelic-assisted therapy. Some argue that the medicines are the primary agents of change, needing only minimal ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, today announced that ...
Understanding Hope and Debunking Its Myths Forge a Valuable Tool for Clinicians Fig 1. Summary of systemic therapy for stage I-III anal SSC recommendations. C, conditional; CRT, chemoradiotherapy; ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Genascence Corporation (“Genascence”), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, ...
Aug 14 (Reuters) - Schrödinger (SDGR.O), opens new tab said on Thursday it has stopped the development of an experimental drug after the death of two patients with a type of blood cancer in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback